PubRank

U Vehling-Kaiser

Author PubWeight™ 13.48‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Treatment of older patients with mantle-cell lymphoma. N Engl J Med 2012 3.46
2 Phase II study of weekly oxaliplatin plus infusional fluorouracil and folinic acid (FUFOX regimen) as first-line treatment in metastatic gastric cancer. Br J Cancer 2005 1.31
3 FOLFIRI plus cetuximab versus FOLFIRI plus bevacizumab as first-line treatment for patients with metastatic colorectal cancer-subgroup analysis of patients with KRAS: mutated tumours in the randomised German AIO study KRK-0306. Ann Oncol 2012 1.08
4 EGFR pathway biomarkers in erlotinib-treated patients with advanced pancreatic cancer: translational results from the randomised, crossover phase 3 trial AIO-PK0104. Br J Cancer 2012 1.07
5 Left-sided primary tumors are associated with favorable prognosis in patients with KRAS codon 12/13 wild-type metastatic colorectal cancer treated with cetuximab plus chemotherapy: an analysis of the AIO KRK-0104 trial. J Cancer Res Clin Oncol 2014 1.07
6 A prospective multicenter phase II study of oral and i.v. vinorelbine plus trastuzumab as first-line therapy in HER2-overexpressing metastatic breast cancer. Ann Oncol 2010 0.99
7 Correlation of capecitabine-induced skin toxicity with treatment efficacy in patients with metastatic colorectal cancer: results from the German AIO KRK-0104 trial. Br J Cancer 2011 0.85
8 High efficacy and low toxicity of weekly docetaxel given as first-line treatment for metastatic breast cancer. Oncology 2005 0.83
9 Weekly docetaxel monotherapy for advanced gastric or esophagogastric junction cancer. Results of a phase II study in elderly patients or patients with impaired performance status. Crit Rev Oncol Hematol 2008 0.81
10 Gemcitabine and carboplatin in intensively pretreated patients with metastatic breast cancer. Oncology 2008 0.80
11 A prospective cohort study on the impact of darbepoetin alfa on quality of life in daily practice following anemia treatment guideline revisions. Curr Med Res Opin 2014 0.78
12 Long-term outcome of hairy cell leukemia treated with 2-chlorodeoxyadenosine. Ann Hematol 1999 0.77
13 Biochemical and cytokinetic characterization of leukemic cells: prediction of treatment results and early diagnosis of relapse. Prog Clin Biol Res 1988 0.75
14 [The Oncologic and Palliative Network Landshut: a problem-solving approach to oncological and palliative care in structurally weak rural areas, with special emphasis on outpatient and inpatient networking]. MMW Fortschr Med 2014 0.75
15 [Fever, acute renal failure and increased alkaline phosphatase]. Internist (Berl) 1992 0.75
16 Low-dose cytosine arabinoside (LD-Ara C) treatment in dysmyelopoietic syndromes (DMPS) and acute myelogenous leukemia (AML). Anticancer Res 1987 0.75
17 [Simultaneous occurrence of acute myeloid leukemia in 2 chemical workers of the same industry]. Onkologie 1987 0.75